Praxis Precision Medicines, Inc. PRAX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s total liabilities?
- Praxis Precision Medicines, Inc. (PRAX) reported total liabilities of $50.24M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s total liabilities changed year-over-year?
- Praxis Precision Medicines, Inc.'s total liabilities increased by 27.1% year-over-year, from $39.52M to $50.24M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s total liabilities has grown at a 30.6% compound annual growth rate (CAGR), from $15.72M to $59.77M.
- What does total liabilities mean?
- The sum of all debts and financial obligations owed by the company.
- How do you interpret total liabilities?
- Increasing total liabilities relative to assets may signal rising financial risk or reliance on external financing.
- How does total liabilities compare across companies?
- Biotech companies often show low total liabilities until they begin commercialization or take on significant debt for operations.